杨逸涵, 李婉慈, 仲斌演, 沈健, & 朱晓黎. (2022). 经肝动脉化疗栓塞术联合卡瑞利珠单抗及阿帕替尼治疗中晚期肝细胞癌的效果及安全性分析. Linchuang gandanbing zazhi, 38(12), 2755-2760. https://doi.org/10.3969/j.issn.1001-5256.2022.12.014
Chicago Style (17th ed.) Citation杨逸涵, 李婉慈, 仲斌演, 沈健, and 朱晓黎. "经肝动脉化疗栓塞术联合卡瑞利珠单抗及阿帕替尼治疗中晚期肝细胞癌的效果及安全性分析." Linchuang Gandanbing Zazhi 38, no. 12 (2022): 2755-2760. https://doi.org/10.3969/j.issn.1001-5256.2022.12.014.
MLA (9th ed.) Citation杨逸涵, et al. "经肝动脉化疗栓塞术联合卡瑞利珠单抗及阿帕替尼治疗中晚期肝细胞癌的效果及安全性分析." Linchuang Gandanbing Zazhi, vol. 38, no. 12, 2022, pp. 2755-2760, https://doi.org/10.3969/j.issn.1001-5256.2022.12.014.
Warning: These citations may not always be 100% accurate.